Erasca, Inc. Common Stock (ERAS) is a publicly traded Healthcare sector company. As of May 21, 2026, ERAS trades at $11.12 with a market cap of $3.19B and a P/E ratio of -25.11. ERAS moved +7.95% today. Year to date, ERAS is +218.63%; over the trailing twelve months it is +768.75%. Its 52-week range spans $1.01 to $24.28. Analyst consensus is buy with an average price target of $20.27. Rallies surfaces ERAS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes ERAS SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $11.12 |
| Market Cap | $3.19B |
| P/E Ratio | -25.11 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.28 |
| 52-Week Low | $1.01 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-124.55M |
| Gross Margin | 0.00% |
11 analysts cover ERAS: 0 strong buy, 9 buy, 1 hold, 1 sell, 0 strong sell. Consensus rating is buy. Average price target: $20.27.